Downstream Manufacturing Webinars
-
Protein Capture Devices For Antibody Purification
11/27/2023
Hear how you can utilize these protein capture devices to achieve 8 to 10 times the productivity of traditional resins in the first step in antibody purification from the product specialist from Gore.
-
Adopting Novel Technologies To Improve Monoclonal Antibody Processes
11/15/2023
What are the four new-edge production technologies that better remove impurities, reduce aggregation and improve stability
-
Strategies To Improve Protein A Resin Cost Effectiveness
11/9/2023
Explore innovative process intensification strategies and practical applications to increase resin utility, resulting in improvements in costs and time efficiencies in Protein A affinity capture.
-
Evaluation Criteria Of Freezer Systems For Bulk Pharmaceuticals
11/1/2023
Review data and evidence that demonstrates the benefits of an integrated approach to achieving critical end-user goals such as scalability, efficiency, sustainability, and optimized process economics.
-
Analyzing Full And Empty AAV Capsid Ratio – In Less Than 5 Minutes
10/24/2023
Presenters show how Capto Q run on an ÄKTA pure 25 chromatography system can be used to determine the percentage of full capsids of AAV8 and AAV9 with low sample consumption.
-
Planning for Success: Supply Resiliency Strategies for Bench to Production
10/18/2023
Build scalable material sourcing strategies for R&D and early phases through to commercialization and learn how to accelerate the development process and ensure the scalability of your biologics.
-
mRNA, TFF, And Next Steps To Tackle mRNA Therapeutic Challenges
10/16/2023
Expert panelists provide commentary on specific steps considered to be challenging in mRNA therapeutic development as well as new technologies in mRNA therapeutic development.
-
Novel Excipients Versus Active Substances And Inflammatory Response
10/16/2023
Novel excipients or active substances? In this segment of Risk Reduction In mRNA Therapeutic Development, we address the debate and discuss LNP-related inflammatory response concerns.
-
LNP Stability In mRNA Therapeutics
10/16/2023
Learn more about LNP complexity, fragility, and other lipid nanoparticle considerations in this segment from the Bioprocess Online Live digital event Risk Reduction In mRNA Therapeutic Development.
-
Therapeutic Market Opportunities For mRNA
10/16/2023
In this segment from the Bioprocess Online Live digital event Risk Reduction In mRNA Therapeutic Development, hundreds of audience members tell us what forms of vaccine and therapeutics they’re developing.